1. nlove21265
2. xuxaparkus
3. eddenusa
4. snoruiz
5. dancebunch
1.xuxaparkus 06/03/2018
Immunomedics Reveals Promising Data for Sacituzumab Govitecan in Patients Heavily Pretreated for Metastatic Estrogen Receptor-Positive Breast Cancer
2.nlove21265 02/08/2018
Beats EPS loss estimates by $0.10. Misses on revenues.
3.eddenusa 04/25/2018
Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC) at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
4.snoruiz 05/21/2018
Submits a BLA
5.xuxaparkus 05/17/2018
Reports 'positive' data for sacituzumab govitecan, its metastatic breast cancer drug
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW